Biology of A&bgr; Amyloid in Alzheimer's Disease

By Wisniewski T.   Ghiso J.   Frangione B.  

Neurobiology of Disease, Vol. 4, Iss. 5, 1997-05 ,pp. : 313-328

Academic Press

Access to resources Recommend Favorite

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos   Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite

Keystone Symposium on Alzheimer’s Disease: beyond amyloid &bgr;

By Fenili Daniela   Wyss-Coray Tony   McLaurin JoAnne   Jaeger Philipp A  

Future Neurology, Vol. 5, Iss. 3, 2010-05 ,pp. : 353-355

Future Medicine

Access to resources Recommend Favorite

Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa   Rosner Margit   Freilinger Angelika   Lubec Gert   Hengstschläger Markus  

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite

Autoantibodies to Amyloid β-Peptide (Aβ) are Increased in Alzheimer’s Disease Patients and Aβ Antibodies Can Enhance Aβ Neurotoxicity: Implications for Disease Pathogenesis and Vaccine Development

By Nath Avindra   Hall Elizabeth   Tuzova Marnia   Dobbs Michael   Jones Melina   Anderson Caroline   Woodward Jerold   Guo Zhihong   Fu Weiming   Kryscio Richard   Wekstein David   Smith Charles   Markesbery William R.   Mattson Mark P.  

NeuroMolecular Medicine, Vol. 3, Iss. 1, 2003-02 ,pp. : 29-40

Humana Press, Inc

Access to resources Recommend Favorite